Panama orders covid vaccine

The National Government announced this Wednesday, November 25, the agreement with Pfizer Panama and BioNTech SE, to acquire three million doses of its candidate BNT162b2 vaccine, based on mRNA, against SARS-CoV-2, subject to the success of the clinical study and regulatory approval in 2021. According to a statement from the Presidency, the terms of the agreement are based on the timeline for deliveries and the volume of doses progressively during the year 2021.